Explorative Clinical Investigation to Investigate the Ability of PreciseInhale to Direct Regional Lung Targeting and Reduce the Degree of Throat Deposition and Subsequent Gastrointestinal Absorption in Healthy Volunteers After Inhalation of Test Drug Substances Via the PreciseInhale System

NCT04946630 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Nebulizers and Vaporizers

Interventions

DEVICE: PreciseInhale
OTHER: Seretide Evohaler forte

Sponsor

Inhalation Sciences Sweden AB

Collaborators

[object Object]
[object Object]
[object Object]